Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 596 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06447532Enrolling by invitation
Machine learning to track inflammation in breast cancer
This study uses a computer program to look at blood test results from women treated for breast cancer. The goal is to see if patterns in inflammation markers can help predict outcomes.
Buenos Aires, Buenos AiresAges 18–75 - NCT06454656Recruiting
Walking practice for kids with Cerebral Palsy
This study tests a motor learning program to help children with Cerebral Palsy improve their walking. If your child has a walking goal and a caregiver who can help at home, this could be a good fit.
Balrath, MeathAges 6–17 - NCT06458153Recruiting
Imaging speech after cerebellar stroke
This study uses brain scans to understand how the brain controls speech in people who have had a cerebellar stroke. It is looking for both stroke survivors and healthy volunteers to compare.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06444425Enrolling by invitation
AI test for heart function using ultrasound
This trial uses artificial intelligence to analyze heart ultrasound images. It aims to see if AI can detect heart function better than standard methods. You may be eligible if you are a cardiology patient having an ultrasound and can return for extra blood pressure checks.
Yiwu, ZhejiangAges 18 years+ - NCT06410157Recruiting
Mindfulness for heart-brain health in adults 50-70
This study tests whether a daily mindfulness practice can help older adults improve how their heart and brain work together. You will do breathing exercises at home and come to USC twice for check-ups, including blood and urine tests and an MRI.
Los Angeles, CaliforniaAges 50–70 - NCT05188183Recruiting
Remote brain stimulation plus hand training for phantom limb pain
This trial tests whether remote brain stimulation (tDCS) combined with sensory (hand/limb) training can reduce phantom limb pain. It also uses computer prediction (“machine learning”) to estimate who is most likely to benefit.
Cambridge, MassachusettsAges 18 years+ - NCT06375460Recruiting
Using real-time glucose feedback to manage type 2 diabetes
This study tests a new program that uses real-time feedback from a continuous glucose monitor (a small sensor that checks your blood sugar) to help you learn how to manage your type 2 diabetes better. It could help you understand how your daily choices affect your blood sugar and improve your control.
Pittsburgh, PennsylvaniaAges 14–26 - NCT06341179Recruiting
Does more sleep help children learn and manage weight?
This study tests whether helping children sleep longer each night can help them learn better and manage their weight. It is for children ages 6–12 who are above a healthy weight and sleep 9 hours or less per night.
CopenhagenAges 6–12 - NCT06328608RecruitingPhase 2/Phase 3
PRX-102 for children with Fabry disease
This study tests a new enzyme replacement therapy called PRX-102 for children with Fabry disease. It aims to see if the drug is safe and helps manage symptoms like pain and eye or skin changes.
Phoenix, ArizonaAges 2–17 - NCT06334120Recruiting
Darolutamide safety study for men with prostate cancer in Korea
This study tracks the safety of the drug darolutamide in Korean men with a type of prostate cancer that has not spread (non-metastatic) or has spread (metastatic) and is still responding to hormone therapy. It aims to see how well patients tolerate the drug in real-world settings.
Multiple LocationsAges 19 years+ - NCT06297161Recruiting
A study of Bosulif for chronic myeloid leukemia
This study watches how well the medicine Bosulif works for adults with chronic myeloid leukemia in everyday medical practice. You can join if you’re already taking Bosulif or starting it soon, as long as you started within the last year.
New York, New YorkAges 20 years+ - NCT06292780RecruitingPhase 1/Phase 2
Testing linvoseltamab for AL amyloidosis that came back
This trial tests a new drug called linvoseltamab for people with AL amyloidosis that has returned or is not responding to treatment. It aims to see if the drug is safe and helps control the disease.
Duarte, CaliforniaAges 18 years+ - NCT06278207Recruiting
Finerenone in real-world diabetes and kidney disease
This study looks at how the medication finerenone works in everyday medical practice for people with type 2 diabetes and certain stages of chronic kidney disease. It aims to see how safe and effective the treatment is outside of a clinical trial setting.
Multiple Locations, New JerseyAges 18 years+ - NCT06275815Recruiting
Parent training for early language skills
This study helps parents use simple learning activities at home to boost their child's language skills. If your child is getting speech therapy (or waiting for it) and has trouble with words, this program might be a good fit.
Columbus, OhioAges 4 years–5.9 years - NCT06269939Recruiting
Memory training for healthy aging and mild memory loss
This study tests a special memory training program for people with mild memory problems (MCI) or healthy aging. It aims to improve how you learn and remember new information using guided methods.
East Hanover, New JerseyAges 60 years+ - NCT06234969Recruiting
Brain stimulation for PTSD: a learning study
This study tests whether a non-invasive brain stimulation technique called cTBS can help people with PTSD learn to overcome fear. You will have brain scans and receive stimulation to see if it improves how your brain processes fear-related memories.
Philadelphia, PennsylvaniaAges 18–60 - NCT06217107Recruiting
Wellness and work support for lupus and lupus nephritis
This study tests a wellness and work support program for women with lupus or lupus nephritis. The goal is to help you manage your health and connect with others through an online program.
Atlanta, GeorgiaAges 18 years+ - NCT06222697Recruiting
Safety study of Jivi for hemophilia A in Korea
This study is checking the safety of Jivi (a Factor VIII medicine) when used in normal medical care for people with hemophilia A in Korea. It is for anyone 12 or older who has used Factor VIII before or is starting Jivi as part of their regular treatment.
Multiple LocationsAges 12 years+ - NCT06197685Recruiting
Combining treatments to improve memory in multiple sclerosis
This trial tests a combination of two approaches to help people with MS improve memory and learning. If you have mild-to-moderate mobility issues and are not very active, you may be able to join.
East Hanover, New JerseyAges 18–70 - NCT06193356Recruiting
Can endoscopists learn to spot scar after polyp removal?
This study tests whether endoscopists can learn to see scarring and find any remaining tissue after polyp removal. It may help improve how doctors check for cancer coming back.
GhentAges 18 years+ - NCT06165341RecruitingPhase 3
Fazirsiran for mild liver scarring in alpha-1 antitrypsin deficiency
This study tests an investigational drug called fazirsiran, which is designed to treat alpha-1 antitrypsin deficiency-related liver disease with mild scarring. The goal is to see if fazirsiran is safe and can improve or slow liver damage in people with the PiZZ genetic type.
Phoenix, ArizonaAges 18–75 - NCT06165952Recruiting
How processed foods affect teen brain and eating habits
This trial studies how eating processed foods affects the brain's reward system and food learning in teens. It uses MRI scans to look at brain activity and may help understand why some foods are hard to resist.
Stanford, CaliforniaAges 13–15 - NCT06118840Recruiting
AI tool for spotting brain aneurysms on CT scans
This trial tests if an AI model can help doctors detect brain aneurysms more accurately on head CT angiograms (CTA). It may lead to earlier treatment and better outcomes.
Hefei, AnhuiAges 18 years+ - NCT06140524RecruitingPhase 2
Study of Linvoseltamab for high-risk MGUS or smoldering myeloma
This trial tests if linvoseltamab can remove abnormal plasma cells that might turn into multiple myeloma. It is for patients with high-risk MGUS (a precancerous condition) or non-high-risk smoldering myeloma who have not yet developed active myeloma.
Baltimore, MarylandAges 18 years+
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 596 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.